Latest Articles

Publication Date
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - MSN

Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment MSN

Published: Oct. 30, 2025, 11:45 a.m.
29-year-old Irish woman with a severe form of endometriosis affecting her heart to travel to Greece for surgery - ProtoThema English

29-year-old Irish woman with a severe form of endometriosis affecting her heart to travel to Greece for surgery ProtoThema English

Published: Oct. 30, 2025, 11:06 a.m.
Feasibility of robotic single-incision colorectal surgery utilizing a multiport robotic platform: a case series.

The advent of a single port robotic platform offers many potential improvements compared with single incision laparoscopy for both patients and surgeons. However, the technology will likely be prohibitively expensive …

Published: Oct. 30, 2025, midnight
Association between exposure to polycyclic aromatic hydrocarbons and reproductive health outcomes: a systematic review and meta-analysis.

Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental pollutants with known harmful effects on human health. However, their specific impact on reproductive outcomes, both cancer-related and non-cancer-related, has not been comprehensively …

Published: Oct. 30, 2025, midnight
Identification of metabolic reprogramming-associated biomarkers in endometriosis through integrated bioinformatics analysis.

Endometriosis (EMs), a common gynecological disorder, involves complex molecular mechanisms. Metabolic reprogramming (MR) has been recognized as a hallmark of EMs, contributing to lesion survival and immune microenvironment remodeling. This …

Published: Oct. 30, 2025, midnight
Integrative microbiome-metabolomics identifies Pseudomonas as a potential pathogenic factor in endometriosis.

Endometriosis (EMS) is a chronic disease characterized by unclear etiology, influenced by various genetic and environmental factors, with no definitive biomarkers available for early screening. Recent studies suggest that the …

Published: Oct. 30, 2025, midnight
Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.

Endometriosis is a common gynecological condition that affects fertility in many women of reproductive age worldwide. This multifaceted disease exhibits a pathogenesis characterized by hormonal and immune system dysregulations, alongside …

Published: Oct. 30, 2025, midnight
Is the EMpressin Injection in ENDOmetrioma eXcision Surgery Useful? The EMENDOX Study.

Background: Endometrioma recurrence after laparoscopic cystectomy remains a clinical challenge in the long-term management of endometriosis. The Empressin Injection Technique (EIT), which involves the use of a vasopressin analog during …

Published: Oct. 30, 2025, midnight
Defects in the DNA Damage Response of Patient-derived Endometriosis Stromal Cells.

With each menstrual cycle, endometrial cells rapidly proliferate and decidualize in preparation for pregnancy. Such rapid proliferation generates replication stress and results in DNA damage with irreparable cells undergoing senescence. …

Published: Oct. 30, 2025, midnight
Insights into endometrial cancer management: a comprehensive guide through multimodality imaging - springermedicine.com

Insights into endometrial cancer management: a comprehensive guide through multimodality imaging springermedicine.com

Published: Oct. 29, 2025, 10:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!